Amanda Cardona Presents IP Workshop to Startups in Parallel18 BioLeap Program

Associate Amanda Cardona presented a workshop on intellectual property to a cohort of startups in the BioLeap program. This cohort is the second of its kind for parallel18—a life sciences incubator in Puerto Rico—and is comprised of thirteen Puerto Rican startups—and one Canadian company operating in Puerto Rico. The startups are working on leading-edge technology in medical devices, gene therapy, diagnostics, environmental sustainability, big data/artificial intelligence, and digital health.

The incubator invites mentors and industry professionals like Amanda to meet with the BioLeap startups and provide real-world insight into legal and business topics that they may encounter along the path to commercialization of their technology. Amanda’s presentation included topics such as types of protectable intellectual property, filing a patent application, patent and trademark strategies, transactions and agreements that may concern or impact IP, and inventions arising out of federal funding. She will also hold open office hours to further support the startups in the cohort with advice on intellectual property issues that may arise in their commercialization journey.

About BioLeap

BioLeap is a life sciences innovation incubator program of parallel 18, led by the Puerto Rico Science, Technology and Research Trust (PRSTRT) to increase economic development through innovation and entrepreneurship in the life sciences sector in key focus areas such as biotechnology, AI-driven medical technologies, genomics, and more. As the only resource for life sciences entrepreneurs in Puerto Rico, BioLeap focuses on closing the gap between cutting-edge local scientific research and its commercialization, thus advancing the establishment of local, inclusive innovation ecosystem. The 14-week program provides access to educational resources for emerging life sciences ventures, such as technical assistance, access to capital, and co-working space. BioLeap is part of PRSTRT’s global accelerator Parallel18, which provides a supportive environment where life sciences entrepreneurs can structure their businesses, launch a functional prototype, and develop patentable technologies with the goal of commercialization for exports worldwide.